Skip to main content
Top
Published in: Abdominal Radiology 1/2013

01-02-2013

CT-Enteroclysis in the preoperative assessment of the small-bowel involvement in patients with peritoneal carcinomatosis, candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Authors: Nikos Courcoutsakis, Apostolos Antonios Tentes, Emmanuel Astrinakis, Petros Zezos, Panos Prassopoulos

Published in: Abdominal Radiology | Issue 1/2013

Login to get access

Abstract

Purpose

To assess the performance of CT-Enteroclysis (CTE) in the preoperative evaluation of the small bowel (SB) involvement in patients with peritoneal carcinomatosis (PC), candidates for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Material and methods

In this prospective study, 48 consecutive patients (37 women, 11 men, mean age: 57.02 years) with PC of different primaries, eligible for cytoreductive surgery and HIPEC underwent CTE before surgery. Lesions were gathered according to their location (SB wall or mesentery), distribution (jejunum/ileum, proximal/distal) and lesion size (LS, where LS0 is the absence of disease, LS1 < 1 cm, LS < 1–5 cm, and LS3 > 5 cm in maximal diameter). The preoperative CTE classification was correlated with surgical scoring of PC in the SB.

Results

CTE was found to have sensitivity 92%, specificity 96%, PPV 97%, NPV 91%, in assessing PC in the SB/mesentery. CTE exhibited “excellent” agreement with surgical classification of disease extent (overall kappa-weighted coefficient of agreement (κ w) was 0.962). Patients (n = 6) found inoperable at surgery manifested extensive plaque-like cover of the SB wall/mesentery on CTE.

Conclusions

CTE may be considered a reliable imaging technique for the preoperative evaluation of the extent and distribution of PC in the SB/mesentery in order to assist surgical planning or to prevent unnecessary surgery.
Literature
2.
go back to reference Sugarbaker PH (2009) From the guest editors: introduction: progress in the management of carcinomatosis. Cancer J 15:182–183PubMedCrossRef Sugarbaker PH (2009) From the guest editors: introduction: progress in the management of carcinomatosis. Cancer J 15:182–183PubMedCrossRef
3.
go back to reference Roviello F, Caruso S, Marrelli D, et al. (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol. doi:10.1016/j.suronc.2010.09.002 Roviello F, Caruso S, Marrelli D, et al. (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol. doi:10.​1016/​j.​suronc.​2010.​09.​002
4.
go back to reference Yang XJ, Huang CQ, Suo T, et al. (2011) Cytoreductive Surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. doi:10.1245/s10434-011-1631-5 Yang XJ, Huang CQ, Suo T, et al. (2011) Cytoreductive Surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. doi:10.​1245/​s10434-011-1631-5
5.
go back to reference Yan TD, Sim J, Morris DL (2007) Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–1817PubMedCrossRef Yan TD, Sim J, Morris DL (2007) Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–1817PubMedCrossRef
6.
go back to reference Yonemura Y, Bando E, Kawamura T, et al. (2007) Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 134:357–373PubMed Yonemura Y, Bando E, Kawamura T, et al. (2007) Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 134:357–373PubMed
7.
go back to reference Cotte E, Passot G, Gilly FN, Glehen O (2010) Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2:31–35PubMedCrossRef Cotte E, Passot G, Gilly FN, Glehen O (2010) Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2:31–35PubMedCrossRef
8.
go back to reference McKenzie S, Artinyan A, Holt AD, et al. (2011) Selection criteria for complete cytoreduction after cytoreductive surgery for peritoneal surface malignancy: lessons learned from our first series of patients. Am Surg 77:430–437PubMed McKenzie S, Artinyan A, Holt AD, et al. (2011) Selection criteria for complete cytoreduction after cytoreductive surgery for peritoneal surface malignancy: lessons learned from our first series of patients. Am Surg 77:430–437PubMed
9.
go back to reference González-Moreno S, González-Bayón L, Ortega-Pérez G, González-Hernando C (2009) Imaging of peritoneal carcinomatosis. Cancer J 15:184–189PubMedCrossRef González-Moreno S, González-Bayón L, Ortega-Pérez G, González-Hernando C (2009) Imaging of peritoneal carcinomatosis. Cancer J 15:184–189PubMedCrossRef
10.
go back to reference Yan TD, Morris DL, Shigeki K, Dario B, Marcello D (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 98:224–227PubMedCrossRef Yan TD, Morris DL, Shigeki K, Dario B, Marcello D (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 98:224–227PubMedCrossRef
11.
go back to reference Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA (2004) The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101:346–352PubMedCrossRef Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA (2004) The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101:346–352PubMedCrossRef
12.
go back to reference Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–333PubMedCrossRef Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–333PubMedCrossRef
13.
go back to reference Esquivel J, Chua TC, Stojadinovic A, et al. (2010) Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102:565–570PubMedCrossRef Esquivel J, Chua TC, Stojadinovic A, et al. (2010) Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102:565–570PubMedCrossRef
14.
go back to reference Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700PubMedCrossRef Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700PubMedCrossRef
15.
go back to reference Piso P, Glockzin G, von Breitenbuch P, et al. (2009) Patient selection for a curative approach to carcinomatosis. Cancer J 15:236–242PubMedCrossRef Piso P, Glockzin G, von Breitenbuch P, et al. (2009) Patient selection for a curative approach to carcinomatosis. Cancer J 15:236–242PubMedCrossRef
16.
go back to reference Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839–849PubMedCrossRef Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839–849PubMedCrossRef
17.
go back to reference Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic Publishers, pp 359–374CrossRef Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic Publishers, pp 359–374CrossRef
18.
go back to reference Boudiaf M, Jaff A, Soyer P, et al. (2004) Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 233:338–344PubMedCrossRef Boudiaf M, Jaff A, Soyer P, et al. (2004) Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 233:338–344PubMedCrossRef
19.
go back to reference Esquivel J, Chua TC (2009) CT versus intraoperative peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: importance of the difference between statistical significance and clinical relevance. Ann Surg Oncol 16:2662–2663PubMedCrossRef Esquivel J, Chua TC (2009) CT versus intraoperative peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: importance of the difference between statistical significance and clinical relevance. Ann Surg Oncol 16:2662–2663PubMedCrossRef
20.
21.
go back to reference Kebapci M, Akca AK, Yalcin OT, et al. (2010) Prediction of suboptimal cytoreduction of epithelial ovarian carcinoma by preoperative computed tomography. Eur J Gynaecol Oncol 31:44–49PubMed Kebapci M, Akca AK, Yalcin OT, et al. (2010) Prediction of suboptimal cytoreduction of epithelial ovarian carcinoma by preoperative computed tomography. Eur J Gynaecol Oncol 31:44–49PubMed
22.
go back to reference Ferrandina G, Sallustio G, Fagotti A, et al. (2009) Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer 101:1066–1073PubMedCrossRef Ferrandina G, Sallustio G, Fagotti A, et al. (2009) Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer 101:1066–1073PubMedCrossRef
23.
go back to reference de Bree E, Koops W, Kröger R, et al. (2006) Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32:65–71PubMedCrossRef de Bree E, Koops W, Kröger R, et al. (2006) Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32:65–71PubMedCrossRef
24.
go back to reference Maglinte DD, Sandrasegaran K, Lappas JC, Chiorean M (2007) CT Enteroclysis Radiol 245:661–671CrossRef Maglinte DD, Sandrasegaran K, Lappas JC, Chiorean M (2007) CT Enteroclysis Radiol 245:661–671CrossRef
25.
go back to reference Pestieau SR, Jelinek JS, Sugarbaker PH (2002) Abdominal and pelvic CT for detection and volume assessment of peritoneal sarcomatosis. Tumori 88:209–214PubMed Pestieau SR, Jelinek JS, Sugarbaker PH (2002) Abdominal and pelvic CT for detection and volume assessment of peritoneal sarcomatosis. Tumori 88:209–214PubMed
26.
go back to reference Yan TD, Haveric N, Carmignani CP, Bromley CM, Sugarbaker PH (2005) Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 91:394–400PubMed Yan TD, Haveric N, Carmignani CP, Bromley CM, Sugarbaker PH (2005) Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 91:394–400PubMed
27.
go back to reference Schwartz B, Bresalier RS, Kim YS (1992) The role of mucin in colon-cancer metastasis. Int J Cancer 52:60–65PubMedCrossRef Schwartz B, Bresalier RS, Kim YS (1992) The role of mucin in colon-cancer metastasis. Int J Cancer 52:60–65PubMedCrossRef
28.
go back to reference Meyers MA (2000) Intraperitoneal spread of malignancies in Dynamic Radiology of the Abdomen, Chapter 4, 5th Edition, New York: Springer, pp 131–235 Meyers MA (2000) Intraperitoneal spread of malignancies in Dynamic Radiology of the Abdomen, Chapter 4, 5th Edition, New York: Springer, pp 131–235
29.
go back to reference Esquivel J, Chua TC (2009) CT versus intraoperative peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: importance of the difference between statistical significance and clinical relevance. Ann Surg Oncol 16:2662–2663PubMedCrossRef Esquivel J, Chua TC (2009) CT versus intraoperative peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: importance of the difference between statistical significance and clinical relevance. Ann Surg Oncol 16:2662–2663PubMedCrossRef
Metadata
Title
CT-Enteroclysis in the preoperative assessment of the small-bowel involvement in patients with peritoneal carcinomatosis, candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Authors
Nikos Courcoutsakis
Apostolos Antonios Tentes
Emmanuel Astrinakis
Petros Zezos
Panos Prassopoulos
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9869-3

Other articles of this Issue 1/2013

Abdominal Radiology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.